GlycoNex Incorporation Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	36.63	14.7	2.54	30.09	5.48	0.45
Revenue Growth (YoY)	217.92%	478.32%	-91.55%	449.50%	1113.97%	-38.56%
Cost of Revenue	13.05	7.38	1.55	16.12	2.01	0.33
Gross Profit	23.58	7.32	1	13.97	3.46	0.13
Selling, General & Admin	48.88	48.89	50.48	55.2	53.38	57.25
Research & Development	198.08	204.55	210.38	197.41	145.01	156.99
Operating Expenses	246.96	253.44	260.86	252.92	198.39	214.24
Operating Income	-223.37	-246.12	-259.86	-238.95	-194.93	-214.12
Interest Expense	-3.01	-3.63	-3.63	-2.75	-	-1.47
Interest & Investment Income	4.71	8.1	9.37	4.59	2.74	3.1
Currency Exchange Gain (Loss)	-4.75	3.46	-0.55	-0.48	-1.07	1.07
Other Non Operating Income (Expenses)	9.93	8.51	17.15	17.76	20.77	18.01
EBT Excluding Unusual Items	-216.49	-229.68	-237.53	-219.82	-172.49	-193.41
Gain (Loss) on Sale of Assets	-	-	73.81	-	-	32
Pretax Income	-216.49	-229.68	-163.72	-219.82	-172.49	-161.41
Income Tax Expense	1.09	0.02	14.65	-	-	1.32
Net Income	-217.59	-229.71	-178.36	-219.82	-172.49	-162.73
Net Income to Common	-217.59	-229.71	-178.36	-219.82	-172.49	-162.73
Shares Outstanding (Basic)	108	108	108	99	97	89
Shares Outstanding (Diluted)	108	108	108	99	97	89
Shares Change (YoY)	-0.00%	0.35%	8.42%	2.49%	9.25%	17.11%
EPS (Basic)	-2.01	-2.12	-1.65	-2.21	-1.78	-1.83
EPS (Diluted)	-2.01	-2.12	-1.65	-2.21	-1.78	-1.83
Free Cash Flow	-172.37	-253.24	-207.34	-176.24	-147.7	-147.46
Free Cash Flow Per Share	-1.59	-2.34	-1.92	-1.77	-1.52	-1.66
Gross Margin	64.38%	49.80%	39.14%	46.42%	63.21%	27.72%
Operating Margin	-609.75%	-1674.14%	-10222.82%	-794.24%	-3560.33%	-47476.50%
Profit Margin	-593.95%	-1562.51%	-7016.60%	-730.67%	-3150.56%	-36082.26%
Free Cash Flow Margin	-470.52%	-1722.63%	-8156.65%	-585.80%	-2697.72%	-32697.12%
EBITDA	-187.95	-211.74	-228.69	-198.99	-154.8	-177.67
D&A For EBITDA	35.42	34.37	31.18	39.96	40.13	36.45
EBIT	-223.37	-246.12	-259.86	-238.95	-194.93	-214.12

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.